Early molecular changes in Huntington’s appear to be largely due to the loss of normal huntingtin protein function, a new study found.| Huntington's Disease News
Several observational studies to help improve knowledge of Huntington's and speed treatment development are now enrolling patients in the U.S.| Huntington's Disease News
Scientists uncovered a Huntington's disease mechanism leading to abnormal toxic protein production that was called "one piece of the puzzle."| Huntington's Disease News
Ingrezza has been associated with sustained reductions in Huntington's chorea, regardless of concurrent antipsychotic medication use.| Huntington's Disease News
Two proteins, neurofilament light chain and phosphorylated tau, can serve as markers of Huntington's disease progression, a study found.| Huntington's Disease News
Category archive page for News.| Huntington's Disease News
Lindsey Shapiro is a science writer for Huntington's Disease News with a PhD in neuroscience. She covers the latest news and information on a variety of Huntington's disease topics.| Huntington's Disease News
Ingrezza Sprinkle is a formulation of oral Ingrezza that's designed to be easier to swallow, with capsule's granules sprinkled on soft foods.| Huntington's Disease News